Purchase Order HHSN272201601028P

This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $6,965.30, is for the production of customized protein production in a baculovirus expression system. The award does not have a set-aside designation. Genscript USA Inc. has received numerous prime and subcontract...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Proteos Inc., a for-profit organization specializing in the production of recombinant proteins. The $24,248.00 contract is for the expression and purification of OTSA and OTSB proteins in insect cells, with a target of 7.5 mg of OTSA and 2.5 mg of OTSB at a purity greater than 90% and low endotoxin levels. The contract has an...

This is a firm fixed price purchase order contract awarded by the Department of Agriculture's Agricultural Research Service to Proteogenix, a for-profit biotechnology manufacturer, for the custom acquisition of baculoviruses expressing proteins from the African Swine Fever Virus (ASFV). The $240,000 contract was awarded on September 22, 2020 with a completion date of September 29, 2021. The contract did not have a set-aside designation, indicating that it was competed in full and open...

This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....

This federal contract award, valued at $13,587.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of a customized protein service in a bacterial expression system, involving the production of 3 mg of protein for 6 different proteins. This purchase order contract has a firm fixed price pricing type and does not utilize any set-aside designations. Genscript...

The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a $20,591.00 firm fixed-price purchase order to Proteos Inc. for custom protein purification and expression services. The contract has an ultimate completion date of April 17, 2015. Proteos Inc. is a for-profit organization that specializes in producing high-quality recombinant proteins, particularly HIV-related proteins, for federal agencies like the Centers for Disease...

This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...

This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...